Cargando…
COVID-19: Coronavirus Vaccine Development Updates
Coronavirus Disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since March 2020 and led to many fatalities. Vaccines represent the most efficient means to control and stop the pandemic of COVID-19. How...
Autores principales: | Zhao, Jing, Zhao, Shan, Ou, Junxian, Zhang, Jing, Lan, Wendong, Guan, Wenyi, Wu, Xiaowei, Yan, Yuqian, Zhao, Wei, Wu, Jianguo, Chodosh, James, Zhang, Qiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785583/ https://www.ncbi.nlm.nih.gov/pubmed/33424848 http://dx.doi.org/10.3389/fimmu.2020.602256 |
Ejemplares similares
-
COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine
por: Guan, Wenyi, et al.
Publicado: (2020) -
Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”
por: Yan, Yuqian, et al.
Publicado: (2020) -
Development and Application of a Fast Method to Acquire the Accurate Whole-Genome Sequences of Human Adenoviruses
por: Zhao, Shan, et al.
Publicado: (2021) -
Characterization of Influenza A and B Viruses Circulating in Southern China During the 2017–2018 Season
por: Yan, Yuqian, et al.
Publicado: (2020) -
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity
por: Ou, Junxian, et al.
Publicado: (2021)